2 completed, 1 terminated. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 2 | Completed 1, Terminated 1 |
Follow PC-786: new trials by email Literature Review of PC-786 trials Research Report on PC-786
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Anti-viral Effect of PC786 on RSV Infection on HSCT Recipients PC786, Placebo, SOC - Respiratory Syncytial Virus Infections | Phase 2 | Terminated | Pulmocide Ltd | 5 | 2018-11-05 | 2019-06-12 |
| A Study of PC786 to Evaluate the Antiviral Activity, Safety and Pharmacokinetics of Multiple Doses in an RSV Challenge Study PC786, Placebo/vehicle - Respiratory Syncytial Virus Infections | Phase 1 / Phase 2 | Completed | Pulmocide Ltd | 56 | 2017-11-14 | 2018-05-16 |
| A Study to Investigate the Safety and Tolerability of Single and Repeat Doses of PC786 PC786 - Single doses, Placebo - Single doses, PC786 - Repeat doses - Respiratory Syncytial Virus (RSV) | Phase 1 | Completed | Pulmocide Ltd | 39 | 2017-06-21 | 2017-12-21 |
Respiratory Syncytial Virus Infections (2)
Pulmocide Ltd (3)
United Kingdom (3)
Alison Murray (1) · Bryan J Murray, MBBS (1) · Malcolm J Boyce, MBChB, MD (1)
2016 (1), 2017 (1), 2018 (1)